Elevated C26 Fatty Acid In Cultured Skin Fibroblasts - PubMed
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Wiley Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- Grants and funding
- LinkOut - more resources
Abstract
Because postmortem brain and adrenal tissue from patients with adrenoleukodystrophy (ALD) or adrenomyeloneuropathy (AMN) have been shown to contain abnormally large amounts of very long chain fatty acids (C24 through C30), we searched for such an abnormality in cultured skin fibroblasts. Total lipid extracts of cultured fibroblasts were hydrolyzed, their fatty acid composition was determined by gas-liquid chromatography, and the ratio of C26 to C22 fatty acids was calculated. In 29 control cell lines this ratio was 0.064 +/- 0.019. In 5 patients with autopsy-proved ALD the ratio was 0.778 +/- 0.139; in 6 patients with clinical features typical of ALD it was 0.764 +/- 0.092; in 2 patients with autopsy-proved AMN, 0.890 +/- 0.02; and in 2 patients with clinical features typical of AMN, 0.560 +/- 0.079. Abnormal ratios were observed in 4 of 5 ALD heterozygotes. In 3 patients in whom the diagnosis of ALD was suspected, an abnormal ratio (0.860) was observed in 1 and normal ratios (0.06 and 0.074) in the 2 others.
PubMed Disclaimer
Publication types
- Research Support, Non-U.S. Gov't Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Research Support, U.S. Gov't, P.H.S. Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Adolescent Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Adrenal Insufficiency / genetics* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Adrenal Insufficiency / metabolism Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Adult Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Cells, Cultured Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Child Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Diffuse Cerebral Sclerosis of Schilder / genetics* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Diffuse Cerebral Sclerosis of Schilder / metabolism Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Fatty Acids / analysis* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Fibroblasts / analysis Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Genetic Carrier Screening Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Male Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Middle Aged Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Skin / analysis* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Syndrome Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Fatty Acids Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- hexacosanoic acid Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Grants and funding
- HD 10981/HD/NICHD NIH HHS/United States
- NS 03356 10885/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
- Wiley
Research Materials
- Coriell Cell Repositories
Wiley [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » C24 Y C26
-
Ácidos Grasos De Cadena Muy Larga
-
Enrichment Of Hydroxylated C24- And C26-acyl-chain Sphingolipids ...
-
Disturbed Very Long Chain (C24–C26) Fatty Acid Pattern In Fibroblasts ...
-
Evaluation Of The Effects Of C22:0, C24:0 And C26:0 On Superoxide ...
-
POX Fatty Acid Profile, Peroxisomal (C22-C26), Serum
-
The Effect Of Enriched Retinal Docosahexaenoic Acid And N-3 Very ...
-
[PDF] Determinación De ácidos Grasos De Cadena Muy Larga En Suero Por ...
-
Determinación De ácidos Grasos De Cadena Muy ... - Medigraphic
-
C26:0-Carnitine Is A New Biomarker For X-Linked ... - NCBI
-
Sphingolipid Metabolism (integrated Pathway) (Mus Musculus)
-
POX - Overview: Fatty Acid Profile, Peroxisomal (C22-C26), Serum
-
Perfil De ácidos Grasos, Peroxisomal (C22-C26), Suero